Overview
Loka’s Agentic Drug Discovery program transforms pharmaceutical research by integrating cutting-edge AI models and databases into a collaborative, streamlined process.
Our engagement begins with a discovery and planning phase, customizing the AI solution to your specific needs. We then develop and integrate leading biological models like ESM, DiffDock, and BioNeMo, facilitating your ability to query both public and private databases through simple conversational interfaces.
The final validation phase ensures the solution is robust, accurate, and ready for deployment, establishing a new benchmark for efficiency and precision in drug discovery.
AWS Tools Used
- Bedrock
- DynamoDB
- RDS
- Fargate
- Route52
- EC2
- ECR
- S3
- Secret Manager
- Amazon Cognito
Highlights
- Conversational & Customizable Access: Researchers can interact with advanced AI models through a simple chat interface, tailored to integrate seamlessly with internal data and workflows—no engineering required.
- Flexible Model & Data Integration: Combine public models (e.g., ESM, DiffDock, BioNeMo) with proprietary models and datasets for a powerful, end-to-end drug discovery toolkit.
- Automated Agentic Workflows: Streamline multi-step research processes—from hypothesis generation to execution—using AI agents that operate autonomously to accelerate discovery.
Details
Introducing multi-product solutions
You can now purchase comprehensive solutions tailored to use cases and industries.
Pricing
Custom pricing options
How can we make this page better?
Legal
Content disclaimer
Support
Vendor support
To schedule a rapid 30-minute consultation email jorge.sampaio@loka.com